Devyser BRCA for NGS

Reduce hands-on time from days to minutes with Devyser’s CE-IVD single tube, next-generation sequencing (NGS) library prep kit for fast and complete characterisation of BRCA1 and BRCA2.

Discover the advantages of Devyser’s NGS workflow

  • Detect all mutations in BRCA1 and BRCA2
  • One tube per sample means no need for sample splitting
  • Reduce hands-on time from days to under 45 minutes
  • One kit for both germline and somatic mutations
  • Choice of several validated software options, including CNV analysis

NGS has never been easier

The Devyser BRCA kit is easy to implement and highly cost-effective, making it a good match for laboratories of any size. With ready-to-use reagents and a user-friendly workflow, it suites both manual and automated workflows. Devyser’s unique single-tube approach simplifies the workflow, reduces hands-on time and minimizes the risk of sample mix-up and contamination. 

The proprietary multiplex PCR primer chemistry provides full and uniform coverage of BRCA1 and BRCA2, covering all exons and exon/intron junctions. The kit uses overlapping primer design to ascertain superior INDEL coverage and downstream CNV analysis. The Devyser BRCA kit can be used to detect both germline and somatic mutations.

Quick and easy implementation

With ready-to-use reagents, less than 45 minutes hands-on time and customised data interpretation software, it is a good match for laboratories of any size. The targeted sequencing approach combined with uniform coverage of target regions maximises the output of relevant sequencing data in every run.

CE-IVD

Certified for In Vitro Diagnostics​

100%

Coverage uniformity >20% mean

<45 min

Hands-on time

>99%

On-target reads

Germline and somatic
Suitable for both germline and somatic (FFPE) BRCA analysis

Analytical software options

Laboratories have a choice of fully validated analytical software solutions, locally deployed or cloud-based. We also support integration with other analytical software solutions.

About BRCA mutation testing

Early identification of germline BRCA mutations can help physicians make informed decisions on risk reduction strategies such as hormone replacement therapy, chemoprevention strategies and prophylactic surgery. Analysis of somatic mutations can help clinicians tailor targeted treatment for ovarian and breast cancer patients.

Whitepapers

Whitepaper NGS GENE SEQUENCING BRCA1 & BRCA2

NGS: Full Gene Sequencing of BRCA1 and BRCA2

With the increasing use of NGS, the number of detected variants in BRCA1 and BRCA2 are increasing fast. As a consequence, the absolute numbers of Variants of Uncertain Significance (VUS) are also increasing. This paper describes current initiatives to classify and interpret VUS in BRCA1 and BRCA2, and how laboratories can contribute to these efforts and ultimately improve the counseling of tested patients.

Find out more about our BRCA NGS products or Contact Us.

Related products

Devyser HBOC

Complete sequencing of 12 genes with a recognised connection to the development of breast and ovarian cancers. CE-IVD

Devyser FH

Single-tube NGS analysis of multiple genes involved in familial hypercholesterolemia (FH/ADH)

Devyser CFTR NGS

Enables fast and complete CFTR gene sequencing including CNV analysis in a single tube, CE-IVD NGS library prep kit

Devyser Chimerism

Devyser Chimerism for NGS provides labs with one simple protocol for fast and reliable Chimerism measurement and monitoring in transplanted patients

Ready to test it out? Contact us here.

Ready to test it out? Order a demo kit here.

Learn more about how our single-tube NGS assay can help your team get the results they need.

Whitepaper

NGS: Full Gene Sequencing of BRCA1 and BRCA2

With the increasing use of NGS, the number of detected variants in BRCA1 and BRCA2 are increasing fast. As a consequence, the absolute numbers of Variants of Uncertain Significance (VUS) are also increasing. This paper describes current initiatives to classify and interpret VUS in BRCA1 and BRCA2, and how laboratories can contribute to these efforts and ultimately improve the counseling of tested patients.

Ready to try it out? Contact us here.

  • This field is for validation purposes and should be left unchanged.

Whitepaper

NGS: Full Gene Sequencing of BRCA1 and BRCA2

With the increasing use of NGS, the number of detected variants in BRCA1 and BRCA2 are increasing fast. As a consequence, the absolute numbers of Variants of Uncertain Significance (VUS) are also increasing. This paper describes current initiatives to classify and interpret VUS in BRCA1 and BRCA2, and how laboratories can contribute to these efforts and ultimately improve the counseling of tested patients.

  • Whitepapers
  • Downloads
  • Product details

IFU and software settings

Enter access code found in the lower right corner of the label on the kit box.

Certificates

Download a specific Batch Release Certificate (BRC) below by entering the BATCH/LOT number and then click on "Find".

Whitepapers

Whitepaper NGS GENE SEQUENCING BRCA1 & BRCA2

NGS: Full Gene Sequencing of BRCA1 and BRCA2

With the increasing use of NGS, the number of detected variants in BRCA1 and BRCA2 are increasing fast. As a consequence, the absolute numbers of Variants of Uncertain Significance (VUS) are also increasing. This paper describes current initiatives to classify and interpret VUS in BRCA1 and BRCA2, and how laboratories can contribute to these efforts and ultimately improve the counseling of tested patients.

Find out more about our BRCA NGS products or Contact Us.

Product details

CE-IVD Certified Kits

Name
Scope
Pack Size
Article Number
Devyser BRCA
Complete sequencing and SNV and CNV determination of the BRCA1, BRCA2 genes
8
8-A100-8
24
8-A100-24
96
8-A100-96

Research Use Only Kits

Name
Scope
Pack Size
Article Number
Devyser BRCA
Complete sequencing and SNV and CNV determination of the BRCA1, BRCA2 genes
8
8-A102-8
24
8-A102-24
96
8-A102-96